Gain Therapeutics (GANX) Institutional Ownership $1.87 +0.06 (+3.31%) Closing price 10/17/2025 04:00 PM EasternExtended Trading$1.82 -0.05 (-2.41%) As of 10/17/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Gain Therapeutics (NASDAQ:GANX)CurrentInstitutional OwnershipPercentage11.97%Number ofInstitutional Buyers(last 12 months)9TotalInstitutional Inflows(last 12 months)$1.16MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$390.93K Get GANX Insider Trade Alerts Want to know when executives and insiders are buying or selling Gain Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data GANX Institutional Buying and Selling by Quarter Gain Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/13/2025Marshall Wace LLP276,433$498K0.0%+41.0%0.919% 8/8/2025Geode Capital Management LLC290,462$523K0.0%+2.9%0.966% 5/13/2025Kovitz Investment Group Partners LLC47,578$91K0.0%N/A0.162% 5/7/2025Dauntless Investment Group LLC125,584$240K0.3%N/A0.427% 2/17/2025Gotham Asset Management LLC158,155$342K0.0%-52.7%0.596% 2/17/2025Bridgeway Capital Management LLC30,004$65K0.0%N/A0.113% 2/14/2025Northern Trust Corp84,586$183K0.0%+88.2%0.319% 2/13/2025Marshall Wace LLP91,738$198K0.0%N/A0.346% 2/12/2025Geode Capital Management LLC267,421$578K0.0%-1.7%1.008% 2/6/2025Jones Financial Companies Lllp98,250$212K0.0%+83.6%0.370% Get the Latest News and Ratings for GANX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gain Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/4/2025Sprott Inc.14,000$30K0.0%N/A0.053% 1/28/2025Benedict Financial Advisors Inc.16,000$35K0.0%N/A0.060% 11/16/2024Geode Capital Management LLC271,972$484K0.0%+48.0%1.065% 8/9/2024Renaissance Technologies LLC118,700$152K0.0%+154.2%0.658% 8/9/2024Warberg Asset Management LLC51,600$66K0.0%N/A0.286% 8/3/2024Hohimer Wealth Management LLC330,000$422K0.1%N/A1.828% 1/16/2024Raymond James & Associates23,788$78K0.0%-29.6%0.184% 7/25/2023Raymond James & Associates33,400$150K0.0%+67.0%0.271% 5/8/2023CM Management LLC90,000$434K0.5%-18.2%0.740% 5/2/2023Wealth Alliance Advisory Group LLC12,502$60K0.0%-33.3%0.105% 4/14/2023Raymond James & Associates20,000$96K0.0%-16.7%0.168% 2/9/2023CM Management LLC110,000$344K0.4%-12.0%0.926% 1/17/2023Wealth Alliance Advisory Group LLC18,751$59K0.0%-25.0%0.158% 11/17/2022Telemetry Investments L.L.C.150,000$489K0.6%-6.3%1.263% 10/25/2022Raymond James & Associates24,000$78K0.0%N/A0.202% 10/12/2022Wealth Alliance Advisory Group LLC25,000$82K0.0%N/A0.210% 5/9/2022CM Management LLC125,000$511K0.4%+38.9%1.052% 2/3/2022Advisor Group Holdings Inc.10,050$54K0.0%N/A0.085% 2/2/2022CM Management LLC90,000$489K0.4%+39.9%0.758% 11/16/2021Telemetry Investments L.L.C.96,232$716K1.0%+217.7%0.810% 11/15/2021Veritable L.P.25,064$187K0.0%N/A0.211% 11/9/2021Indie Asset Partners LLC29,652$221K0.2%N/A0.250% 11/8/2021CM Management LLC64,327$479K0.4%+543.3%0.542% 8/17/2021Bridgeway Capital Management LLC50,000$501K0.0%N/A0.421% 8/16/2021Telemetry Investments L.L.C.30,293$303K0.4%N/A0.255% (Data available from 1/1/2016 forward) GANX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GANX shares? During the previous two years, 14 institutional investors and hedge funds held shares of Gain Therapeutics. The most heavily invested institutionals were Geode Capital Management LLC ($523K), Marshall Wace LLP ($498K), Hohimer Wealth Management LLC ($422K), Gotham Asset Management LLC ($342K), Dauntless Investment Group LLC ($240K), Jones Financial Companies Lllp ($212K), and Northern Trust Corp ($183K).Learn more on Gain Therapeutics' institutional investors. What percentage of Gain Therapeutics' stock is owned by institutional investors? 11.97% of Gain Therapeutics' stock is owned by institutional investors. Learn more on GANX's institutional investor holdings. Which institutional investors have been buying Gain Therapeutics' stock? Of the 12 institutional investors that purchased Gain Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Hohimer Wealth Management LLC ($330K), Marshall Wace LLP ($172.15K), Dauntless Investment Group LLC ($125.58K), Geode Capital Management LLC ($96.49K), Renaissance Technologies LLC ($72K), Warberg Asset Management LLC ($51.60K), and Kovitz Investment Group Partners LLC ($47.58K). How much institutional buying is happening at Gain Therapeutics? Institutional investors have bought a total of 586,190 shares in the last 24 months. This purchase volume represents approximately $1.16M in transactions. Which of Gain Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Gain Therapeutics stock in the last 24 months: Gotham Asset Management LLC ($176.44K), and Geode Capital Management LLC ($4.55K). How much institutional selling is happening at Gain Therapeutics? Institutional investors have sold a total of 180,988 shares in the last 24 months. This volume of shares sold represents approximately $390.93K in transactions. Related Companies Galectin Therapeutics Major Shareholders Tenaya Therapeutics Major Shareholders SOPHiA GENETICS Major Shareholders Tectonic Therapeutic Major Shareholders Abeona Therapeutics Major Shareholders Zura Bio Major Shareholders Adherex Technologies Major Shareholders Humacyte Major Shareholders Ventyx Biosciences Major Shareholders Voyager Therapeutics Major Shareholders This page (NASDAQ:GANX) was last updated on 10/18/2025 by MarketBeat.com Staff From Our PartnersHoly ****... This could actually MAGAA new document circulating from Washington is stirring major controversy — one that some say could redefine Am...StocksToTrade | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredThe $20 stock that could make silicon chips obsolete$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gain Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gain Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
